• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Myelodysplastic Syndrome

In a healthy body, bone marrow produces immature cells that develop into red blood cells white blood cells as well as platelets. In MDS the bone marrow makes too many of these immature cells, referred to as blasts. These cells block healthy, mature cells.

Chronic myelomonocytic leukemia (CMML). This is the most common MDS subtype.

Anemia

In patients suffering from myelodysplastic disorder the immature blood cells referred to as blasts don't grow into healthy white blood cells, red blood cells or platelets. This makes it difficult to grow healthy blood cells to form in the bone marrow. The result is anemia which causes tiredness. It also may make bleeding complications and infections more likely.

The immature cells usually die in bone-marrow shortly after they enter the bloodstream. The disease may transform into leukemia which is more invasive and has a better prognosis (chance of recovery).

MDS is classified into subtypes according to the type of blood cells affected. There are subgroups that have myelodysplastic syndrome with leukemia. At OSUCCC - James, hematologists and subspecialists collaborate to create personalized treatments that are specific to each patient's condition. Radiation oncologists, molecular pathologists and other specialists are included in this group. They employ a variety of treatments and treatments, including experimental ones in clinical trials.

Bleeding

In patients suffering from myelodysplastic disorder blood-forming cells that normally develop into healthy red blood cells white blood cells or platelets are abnormal. This may result in a reduced number of mature blood cells, which could lead to serious health issues.

These blood cells are produced in the bone marrow, which is located inside of your bones. The blood cells are released into the bloodstream and circulate throughout the body. The blood that circulates outside the bone marrow is known as peripheral blood.

Platelets stop bleeding following an injury. Platelets can also aid in reducing bleeding after surgery or during an illness.

Your doctor will be able to diagnose myelodysplastic syndrome by looking at your blood and bone marrow sample. Your doctor or technician will insert an needle into your breastbone or hip to take a small sample of bone marrow. The doctor will analyze the bone marrow using an optical microscope. Blood samples are also taken for checking your CBC and to check for cytogenetic and genetic changes (see the image below). There are several subtypes of the myelodysplastic disorder. These subtypes are determined by the type of blood cell affected as well as their unusual appearance under microscope.

Infections

In MDS blood cells that are immature called blasts can swell out healthy, mature cells. This may result in the absence of healthy red blood (anemia), or white blood (neutropenia) or platelets (thrombocytopenia). If there are too many blasts, it will be classified as acute myelogenous (AML).

There are various types of myelodysplastic disorder. Doctors categorize them according to whether or not chromosomes have changed and the kind of blood cells affected. There are different groups based on the look of blood cells under a magnifying lens.

The World Health Organization divides myelodysplastic disorders into subtypes. Refractory Cytopenia with Unilineage dysplasia: When examining cells under a magnifying glass, providers can observe that there are too few red blood cells. However, they may also see changes on your del (5q chromosome).

Certain types of MDS may develop into acute myelogenous lymphoma (AML), which is more difficult to treat than MDS. About a third of MDS patients progress to AML. The risk factors for this include age, treatment with chemotherapy or radiation for other cancers, and exposure to chemicals such as fumes, pesticides and fertilizers and solvents, and heavy metals such as lead and mercury.

Surgery

In a healthy person the bone marrow produces mature blood cells that are able to enter the bloodstream. In myelodysplastic diseases, immature cells can clog the bone marrow, causing problems like anemia, recurrent infection and bleeding that doesn't stop. The condition may progress into acute myeloid cancer, an illness that affects the bone marrow and blood cells.

The condition can be diagnosed by bone marrow and blood tests. Certain factors can increase the risk, including age as well as previous treatment with chemotherapy or Myelodysplastic Syndrome Railroad cancer settlements radiation therapy to treat another disease. Smokers are also at a higher-risk of developing these illnesses.

Certain doctors treat Myelodysplastic Syndrome Railroad cancer settlements disorder with chemotherapy to kill cancer cells and other healthy cells. They then replace the blood-forming cells using stem cells from the patient or donor. The stem cells transform into blood-forming cells that restore blood supply to your body. This kind of treatment can help prolong survival, but it doesn't always treat the condition. The right surgeon can make a significant difference in how successful the procedure is and the speed at which a patient can return to routine activity.

Treatment

Myelodysplastic Syndrome is treated by decreasing symptoms, reducing the progress of the disease and preventing complications. Blood transfusions and medicines to increase the production of blood cells can help. A bone marrow transplant which replaces the damaged bone marrow with healthy stem cells from a donor, is sometimes utilized for serious cases.

Doctors categorize myelodysplastic disorder into subtypes, based on the blood type that is involved. They also examine the changes that occur in blood cells and bone marrow.

Certain types of myelodysplastic disease are characterized by a low number of healthy red blood cells (anemia), white blood cells (leukopenia) and platelets (thrombocytopenia). Certain forms of myelodysplastic syndrome have a large number of immature cells known as blasts, that are affluent in the bone marrow. Blasts are not matured into healthy cells but can be transformed into acute leukemia.

Your doctor may suggest that you participate in a clinical study. A clinical trial is a study to find out whether new treatments are safe and effective. For information about taking part in a trial that is clinical, see the NCI's Cancer Clinical Trials page. This PDQ cancer information summary was updated and reviewed in June 2016. It is intended for general education only. Individuals should consult a licensed health professional for expert medical advice as well as diagnosis and treatment for any health or medical issue.